Mechanisms of disease: Mitochondria as new therapeutic targets in diabetic neuropathy

Nature Clinical Practice Neurology

Volumn 2, Issue 11, 2006, Pages 620-628

  Leinninger, Gina M ^a   Edwards, James L ^a   Lipshaw, Matthew J ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; INSULIN; MITOCHONDRIAL DNA; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PROTEIN BAX INHIBITOR; PROTEIN BCL INHIBITOR; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL DAMAGE; CELL FUNCTION; CELL FUSION; CELL LOSS; CELL SHAPE; CELL SIZE; CELL STRUCTURE; DIABETIC NEUROPATHY; DIABETOGENESIS; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; GENE MUTATION; GENETIC CODE; GENETIC RISK; HUMAN; HYPERGLYCEMIA; LOW DRUG DOSE; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL MEMBRANE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; SCHWANN CELL; SPINAL GANGLION;

ANIMALS; DIABETIC NEUROPATHIES; HUMANS; HYPERGLYCEMIA; MITOCHONDRIA; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES;

EID: 33750300252     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0320     Document Type: Review

References (67)

1. Mokdad AH et al. (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286: 1195-1200
2. Sheetz MJ and King GL (2002) Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288: 2579-2588
3. Feldman EL et al. (1999) Diabetic neuropathy. In Current Review of Diabetes, 71-83 (Ed. Taylor S) Philadelphia: Current Medicine
4. Vileikyte L (2001) Diabetic foot ulcers: A quality of life issue. Diabetes Metab Res Rev 17: 246-249
5. Ramsey SD et al. (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22: 382-387
6. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
7. [No authors listed] (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853
8. Kalichman MW et al. (1998) Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol (Berl) 95: 47-56
9. Chopra JS et al. (1977) Pathology and time relationship of peripheral nerve changes in experimental diabetes. J Neurol Sci 32: 53-67
10. Sendtner M et al. (1991) Effect of ciliary neurotrophic factor (CNTF) on motoneuron survival. J Cell Sci Suppl 15: 103-109
11. Greene DA et al. (1992) Complications: Neuropathy, pathogenetic considerations. Diabetes Care 15: 1902-1925
12. Schmeichel AM et al. (2003) Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52: 165-171
13. Sima AAF et al. (1988) Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstrations of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349-364
14. Llewelyn JG et al. (1991) Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. Brain 114: 867-892
15. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820
16. Stevens MJ et al. (2002) Pathogenesis of diabetic neuropathy. In Ellenberg and Rifkin's Diabetes Mellitus, 747-770 (Eds Porte D Jr et al.) New York: McGraw Hill
17. Cameron NE et al. (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44: 1973-1988
18. Bach D et al. (2005) Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: Effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor [alpha] and interleukin-6. Diabetes 54: 2685-2693
19. Bach D et al. (2003) Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: A novel regulatory mechanism altered in obesity. J Biol Chem 278: 17190-17197
20. Russell JW et al. (2002) High glucose induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16: 1738-1748
21. Vincent AM et al. (2005) Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 19: 638-640
22. Vincent AM et al. (2005) Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Antiox Redox Signal 7: 1494-1506
23. Leinninger GM et al. (2004) Insulin-like growth factor-I (IGF-I) regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma. Cell Death Differ 11: 885-896
24. Leinninger GM et al. (2004) Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB J 18: 1544-1546
25. Kim JY et al. (2005) Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Neurology 64: 966-972
26. Harrison JF et al. (2005) Oxidative stress-induced apoptosis in neurons correlates with mitochondrial DNA base excision repair pathway imbalance. Nucleic Acids Res 33: 4660-4671
27. Ryu H et al. (2005) Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. Proc Natl Acad Sci USA 102: 13915-13920
28. Mehrabian Z et al. (2005) Regulation of mitochondrial gene expression by energy demand in neural cells. J Neurochem 93: 850-860
29. Peltier AC and Russell JW (2002) Recent advances in drug-induced neuropathies. Curr Opin Neurol 15: 633-638
30. Raff MC et al. (2002) Axonal self-destruction and neurodegeneration. Science 296: 868-871
31. Greene DA et al. (1999) Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol 375: 217-223
32. Russell JW et al. (1999) Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6: 347-363
33. Cheng C and Zochodne DW (2003) Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 52: 2363-2371
34. Srinivasan S et al. (2000) Diabetic peripheral neuropathy: Evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49: 1932-1938
35. Zochodne DW et al. (2001) Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. Brain 124: 2319-2334
36. Raff MC et al. (2002) Axonal self-destruction and neurodegeneration. Science 296: 868-871
37. Cellerino A et al. (2000) Apoptosis in the developing visual system. Cell Tissue Res 301: 53-69
38. Graham SH et al. (2000) Bcl-2 family gene products in cerebral ischemia and traumatic brain injury. J Neurotrauma 17: 831-841
39. Yamaguchi H and Wang HG (2002) Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL. J Biol Chem 277: 41604-41612
40. Eskes R et al. (2000) Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20: 929-935
41. Marani M et al. (2002) Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol 22: 3577-3589
42. Uo T et al. (2004) Neurons exclusively express N-BAK, a BH3 domain-only BAK isoform that promotes neuronal apoptosis. J Biol Chem 250: 9065-9073
43. Degli EM and Dive C (2003) Mitochondrial membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun 304: 455-461
44. Makin GW et al. (2001) Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate. EMBO J 20: 6306-6315
45. Antonsson B et al. (2000) Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345 Pt 2: 271-278
46. Kuwana T et al. (2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111: 331-342
47. Ahmad KA et al. (2004) Hydrogen peroxide-mediated cytosolic acidification is a signal for mitochondrial translocation of Bax during drug-induced apoptosis of tumor cells. Cancer Res 64: 7867-7878
48. Perier C et al. (2005) Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci USA 102: 19126-19131
49. Leinninger GM et al. (2006) Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol Dis 23: 11-22
50. Rube DA and van der Bliek AM (2004) Mitochondrial morphology is dynamic and varied. Mol Cell Biochem 256-257: 331-339
51. Karbowski M and Youle RJ (2003) Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ 10: 870-880
52. 2+-mediated apoptosis. Mol Cell 16: 59-68 Nature PublishingGroup c2006
53. Karbowski M et al. (2004) Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol 164: 493-499
54. Züchner S et al. (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36: 449-451
55. Delettre C et al. (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26: 207-210
56. Lee YJ et al. (2004) Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15: 5001-5011
57. Karbowski M et al. (2002) Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol 159: 931-938
58. Arai R et al. (2004) Establishment of stable hFis1 knockdown cells with an siRNA expression vector. J Biochem (Tokyo) 136: 421-425
59. Frank S et al. (2001) The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 1: 515-525
60. Yu T et al. (2006) Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103: 2653-2658
61. Sundkvist G et al. (2000) Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance. Diabet Med 17: 259-268
62. Rudofsky G Jr et al. (2006) Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes. Diabetes Care 29: 89-94
63. Brussee V et al. (2004) Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53: 1824-1830
64. Huang TJ et al. (2005) Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats. Exp Neurol 194: 279-283
65. Huang TJ et al. (2003) Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52: 2129-2136
66. Ilnytska O et al. (2006) Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 55: 1686-1694
67. Bouchier-Hayes L et al. (2005) Mitochondria: Pharmacological manipulation of cell death. J Clin Invest 115: 2640-2647